Japanese firm Otsuka Pharmaceuticals, Myers-Squibb, Novartis are deferring launch of medicines critical for treatment of serious non-commun...

BDR Pharma has filed an application with the Mumbai Patent Office, seeking compulsory licence to market a crucial cancer drug, dasatinib

Cipla was selling a generic version of the drug at one-fourth the price charged by Sugen Inc and Pharmacia & Upjohn Company.

The Supreme Court today stayed for a month a Delhi High Court order restraining pharma major Cipla from marketing its anti-cancer drug "Sun...

The finance ministry is understood to be also considering hiking the weighted deduction on expenditure on R&D) by drug companies to 200% fr...